| Description |
| Product Type |
Product Size |
| Syrup |
1'S |
| Product Company |
| Reckit Benckiser |
Alginate compound 120ml |
| Product Type |
Product Size |
| Syrup |
1'S |
| Product Company |
| Highnoon Lab |
Sucralfate 120ml
|
| Product Type |
Product Size |
| Tablet |
600'S |
| Product Company |
| Pfizer |
Mefenamic acid 250mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Sandoz |
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
AJM Pharmaceuticals |
|
| Content | Gaviscon offers fast acting heartburn and indigestion relief and treats acid reflux. Explore the Gaviscon range and how it can help. | " Sucralfate is a gastro-duodenal protective agent used in the treatment of gastric and duodenal ulcers and to prevent duodenal ulcer recurrence. "
| Mefenamic acid is used for the short-term relief of mild to moderate pain from various conditions such as headache, dental pain, menstrual cramps, and muscle aches.Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. | Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Docetaxel is a chemotherapy medication used to treat a number of types of cancer.This includes breast cancer , head and neck cancer , stomach cancer , Prostate cancer ,and non small cell lung cancer. It may be used by itself or along with other chemothearpy medication. | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
Reviews
There are no reviews yet.